Abstract:Background Predicting clinical outcomes after cardiac resynchronization therapy (CRT) and its optimization remain a challenge. We sought to determine whether pre‐ and postimplantation QRS area (QRS area ) predict clinical outcomes after CRT. Methods and Results In this retrospective study, QRS area , derived from pre‐ and postimplantation vectorcardiography, were assessed in relation to the primary end point of cardiac mortality after CRT with or without defibrillation. Other end points included total mortality, total mortality or heart failure (HF) hospitalization, total mortality or major adverse cardiac events, and the arrhythmic end point of sudden cardiac death or ventricular arrhythmias with or without a shock. In patients (n=380, age 72.0±12.4 years, 68.7% male) undergoing CRT over 7.7 years (median follow‐up: 3.8 years [interquartile range 2.3–5.3]), preimplantation QRS area ≥102 μVs predicted cardiac mortality (HR: 0.36; P <0.001), independent of QRS duration (QRSd) and morphology ( P <0.001). A QRS area reduction ≥45 μVs after CRT predicted cardiac mortality (HR: 0.19), total mortality (HR: 0.50), total mortality or heart failure hospitalization (HR: 0.44), total mortality or major adverse cardiac events (HR: 0.43) (all P <0.001) and the arrhythmic end point (HR: 0.26; P <0.001). A concomitant reduction in QRS area and QRSd was associated with the lowest risk of cardiac mortality and the arrhythmic end point (both HR: 0.12, P <0.001). Conclusions Pre‐implantation QRS area , derived from vectorcardiography, was superior to QRSd and QRS morphology in predicting cardiac mortality after CRT. A postimplant reduction in both QRS area and QRSd was associated with the best outcomes, including the arrhythmic end point. Clinical Perspective What Is New? Pre‐implantation QRS area was superior to QRSd and QRS morphology in predicting cardiac and total mortality after cardiac resynchronization therapy. Concomitant reductions in QRS area and QRSd after cardiac resynchronization therapy were associated with the best survival and the lowest risk of heart failure hospitalization, major adverse cardiac events as well as ventricular arrhythmias. What Are the Clinical Implications? Reductions in QRS area and QRSd could be a focus for optimization after cardiac resynchronization therapy implantation. Introduction Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. 1 As with any medical therapy, its treatment effect is variable. "Nonresponder" rates range from 9% to 68%, depending on the criteria used to define response. 2 Although no medical therapy can be expected to be 100% effective, there is a consensus view that response to CRT can be improved. 3 Manifold imaging studies explored mechanical dyssynchrony in relation to patient selection and optimization but, ultimately, no single measure of mechanical dyssynchrony has been adopted by clinical guidelines. 4 In this context, we should consider CRT is an electrical treatment and that its substrate should be electrical rather than mechanical. In this respect, QRS duration (QRSd) has been adopted as a surrogate of electrical dyssynchrony in randomized, controlled trials, 1 and a reduction in QRSd has been shown to predict better long‐term outcomes after CRT. 5 , 6 Evidence has recently emerged in support of vectorcardiography in the field of CRT. In this respect, QRS area (QRS area ) has been shown to correlate with LV lateral wall activation time, 7 the maximum rate of rise of LV pressure (ΔLV dP/dt max ), 8 , 9 and LV reverse remodeling<a class="tab-li -Abstract Truncated-

CRT Efficacy in “Mid-Range” QRS Duration among Asians Contrasted to Non-Asians, and Influence of Height

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

Clinical Utility of QRS Duration Normalized to Left Ventricular Volume for Predicting Cardiac Resynchronization Therapy Efficacy in Patients with "Mid-Range" QRS Duration

Prediction of CRT response using a novel CRT responder score in an Asian patient population

Value of QRS duration in predicting response to cardiac resynchronization therapy in patients with end-stage heart failure

Comparison of Efficacy of Reverse Remodeling and Clinical Improvement for Relatively Narrow and Wide QRS Complexes after Cardiac Resynchronization Therapy for Heart Failure

Relationship between Sex, Body Size, and Cardiac Resynchronization Therapy Benefit: A Patient Level Meta-Analysis of Randomized Controlled Trials

Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120-149 ms: Reduction in heart failure hospitalizations and improvement in functional outcome

Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial

Predictors for Cardiac Resynchronization Therapy Response

Prognostic Implications of QRS Duration in Third-Degree Atrioventricular Block Patients with Heart Failure Treated with Cardiac Resynchronization Therapy.

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias.

Efficacy research of cardiac resynchronization therapy in heart failure with narrow QRS complexes

[Role of Electrocardiogram in Predicting Cardiac Resynchronization Therapy Response].

Impact of postoperative QRS duration change on cardiac resynchronization therapy

Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials

Beating the clock: the impact of heart failure duration on CRT efficacy

Cardiac Resynchronization Therapy Improves Myocardial Conduction

Impact of Interlead Distance on Immediate and Mid-Term Response to Cardiac Resynchronization Therapy

Interaction of left ventricular size with the outcome of cardiac resynchronization therapy in Japanese patients